Tagged immunomodulatory

Press Release

iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology

 iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. Read More
Is Your Biotherapeutic Immunomodulatory? How to Use Immunoassays to Get the Right Answer - New Webinar Hosted by Xtalks
Press Release

Is Your Biotherapeutic Immunomodulatory? How to Use Immunoassays to Get the Right Answer - New Webinar Hosted by Xtalks

 Read More
Longevity Biotech and University of Nebraska Medical Center Awarded Continuing Grant from the Michael J. Fox Foundation for Parkinson's Research
Press Release

Longevity Biotech and University of Nebraska Medical Center Awarded Continuing Grant from the Michael J. Fox Foundation for Parkinson's Research

 Furthers development of LBT-3627 focusing on immunomodulatory therapeutic strategy to treat Parkinson's disease Read More
Press Release

IMER Announces Live Advanced Melanoma Webcast During a 1-Day CME-Certified Conference for Community

 Jeffrey S. Weber, MD, PhD, of the H. Lee Moffitt Cancer Center leads a 1-day conference to provide clinicians with an update on the science of melanoma, pertinent clinical trial information, investigational agents, and their unusual adverse effects. Read More